Tetraphase Pharmaceuticals
Biotechnology ResearchMassachusetts, United States11-50 Employees
Tetraphase Pharmaceuticals is a biotechnology research company based in Watertown, Massachusetts, focused on addressing the global threat of antibiotic resistance. It seeks to make novel antibiotics accessible to patients in need by advancing candidates that can overcome drug-resistant bacteria. The firm's size and technology enable exploring a broad range of antibiotic solutions aligned with a clear mission. Its lead product, XERAVA, has received regulatory approval for the treatment of complicated intra-abdominal infections. The company operates within the biotechnology sector, prioritizing the development of treatments to help ensure future availability of effective options. While based in Watertown, the organization maintains a relatively small to mid-sized team focused on its scientific and clinical pursuits.